Clinical Trial Update: Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial combining uproleselan, azacitidine, and venetoclax in newly diagnosed acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Uproleselan (uproleselan)
• Venetoclax (venetoclax)

Snippet

Sponsor: Brian Jonas | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED